celecoxib has been researched along with Pseudomyxoma Peritonei in 1 studies
Pseudomyxoma Peritonei: A peritoneal adenocarcinoma characterized by build-up of MUCUS in the PERITONEAL CAVITY. Mucus secreting cells may attach to the peritoneal lining and continue to secrete mucus. The majority of cases represent tumor spread from a primary low-grade mucinous neoplasm of the APPENDIX (NCI Thesaurus).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudry, HA | 1 |
| Mavanur, A | 1 |
| O'Malley, ME | 1 |
| Zeh, HJ | 1 |
| Guo, Z | 1 |
| Bartlett, DL | 1 |
1 other study available for celecoxib and Pseudomyxoma Peritonei
| Article | Year |
|---|---|
Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Appendiceal Neoplasms; Celecoxib; Colonic N | 2012 |